![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ATAD3C |
Gene summary for ATAD3C |
![]() |
Gene information | Species | Human | Gene symbol | ATAD3C | Gene ID | 219293 |
Gene name | ATPase family AAA domain containing 3C | |
Gene Alias | ATAD3C | |
Cytomap | 1p36.33 | |
Gene Type | protein-coding | GO ID | GO:0006996 | UniProtAcc | Q5T2N8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
219293 | ATAD3C | P2T-E | Human | Esophagus | ESCC | 3.08e-03 | 1.86e-02 | 0.1177 |
219293 | ATAD3C | P4T-E | Human | Esophagus | ESCC | 6.57e-08 | 1.85e-01 | 0.1323 |
219293 | ATAD3C | P8T-E | Human | Esophagus | ESCC | 9.61e-21 | 3.66e-01 | 0.0889 |
219293 | ATAD3C | P10T-E | Human | Esophagus | ESCC | 7.94e-04 | 4.65e-02 | 0.116 |
219293 | ATAD3C | P11T-E | Human | Esophagus | ESCC | 2.21e-03 | 1.61e-01 | 0.1426 |
219293 | ATAD3C | P20T-E | Human | Esophagus | ESCC | 2.27e-06 | 1.40e-01 | 0.1124 |
219293 | ATAD3C | P24T-E | Human | Esophagus | ESCC | 2.73e-07 | 6.10e-02 | 0.1287 |
219293 | ATAD3C | P27T-E | Human | Esophagus | ESCC | 2.65e-11 | 2.21e-01 | 0.1055 |
219293 | ATAD3C | P28T-E | Human | Esophagus | ESCC | 3.09e-02 | 4.04e-02 | 0.1149 |
219293 | ATAD3C | P54T-E | Human | Esophagus | ESCC | 2.72e-02 | 5.67e-02 | 0.0975 |
219293 | ATAD3C | P57T-E | Human | Esophagus | ESCC | 1.80e-05 | 1.69e-01 | 0.0926 |
219293 | ATAD3C | P65T-E | Human | Esophagus | ESCC | 5.88e-27 | 5.13e-01 | 0.0978 |
219293 | ATAD3C | P74T-E | Human | Esophagus | ESCC | 9.43e-22 | 3.87e-01 | 0.1479 |
219293 | ATAD3C | P75T-E | Human | Esophagus | ESCC | 4.79e-09 | 1.84e-01 | 0.1125 |
219293 | ATAD3C | P76T-E | Human | Esophagus | ESCC | 1.06e-03 | 1.08e-01 | 0.1207 |
219293 | ATAD3C | P128T-E | Human | Esophagus | ESCC | 1.04e-18 | 5.88e-01 | 0.1241 |
219293 | ATAD3C | P130T-E | Human | Esophagus | ESCC | 4.18e-09 | 2.53e-01 | 0.1676 |
219293 | ATAD3C | HCC1 | Human | Liver | HCC | 5.89e-12 | 1.10e+00 | 0.5336 |
219293 | ATAD3C | HCC2 | Human | Liver | HCC | 4.90e-35 | 2.82e+00 | 0.5341 |
219293 | ATAD3C | HCC5 | Human | Liver | HCC | 1.40e-27 | 1.46e+00 | 0.4932 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ATAD3C | SNV | Missense_Mutation | novel | c.22N>A | p.Leu8Met | p.L8M | Q5T2N8 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.99) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ATAD3C | SNV | Missense_Mutation | rs553622113 | c.389N>A | p.Arg130Gln | p.R130Q | Q5T2N8 | protein_coding | tolerated(0.16) | benign(0.006) | TCGA-EY-A1G7-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
ATAD3C | SNV | Missense_Mutation | c.9G>T | p.Lys3Asn | p.K3N | Q5T2N8 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.981) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD | |
ATAD3C | SNV | Missense_Mutation | rs774502243 | c.365G>A | p.Arg122Gln | p.R122Q | Q5T2N8 | protein_coding | tolerated(0.47) | benign(0.034) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
ATAD3C | SNV | Missense_Mutation | c.401N>C | p.Ser134Thr | p.S134T | Q5T2N8 | protein_coding | tolerated(0.11) | benign(0.015) | TCGA-49-AAR9-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD | |
ATAD3C | SNV | Missense_Mutation | novel | c.791N>T | p.Arg264Leu | p.R264L | Q5T2N8 | protein_coding | tolerated(0.06) | probably_damaging(0.982) | TCGA-55-7227-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | carboplatin | SD |
ATAD3C | SNV | Missense_Mutation | novel | c.492N>T | p.Lys164Asn | p.K164N | Q5T2N8 | protein_coding | deleterious(0) | possibly_damaging(0.873) | TCGA-33-4566-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
ATAD3C | SNV | Missense_Mutation | c.183C>A | p.Phe61Leu | p.F61L | Q5T2N8 | protein_coding | tolerated(0.63) | benign(0.015) | TCGA-56-A62T-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | carboplatin | CR | |
ATAD3C | SNV | Missense_Mutation | novel | c.1204C>T | p.Pro402Ser | p.P402S | Q5T2N8 | protein_coding | tolerated_low_confidence(0.09) | benign(0.003) | TCGA-F7-A624-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
ATAD3C | SNV | Missense_Mutation | rs746415388 | c.359C>T | p.Ala120Val | p.A120V | Q5T2N8 | protein_coding | tolerated(0.13) | benign(0.017) | TCGA-XK-AAIW-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Unknown | Unknown | PD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |